168 related articles for article (PubMed ID: 28396920)
1. The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance.
Tamada T; Dani H; Taneja SS; Rosenkrantz AB
Abdom Radiol (NY); 2017 Sep; 42(9):2340-2345. PubMed ID: 28396920
[TBL] [Abstract][Full Text] [Related]
2. Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy.
Rosenkrantz AB; Meng X; Ream JM; Babb JS; Deng FM; Rusinek H; Huang WC; Lepor H; Taneja SS
J Magn Reson Imaging; 2016 Feb; 43(2):325-32. PubMed ID: 26131965
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy.
Rosenkrantz AB; Ream JM; Nolan P; Rusinek H; Deng FM; Taneja SS
AJR Am J Roentgenol; 2015 Dec; 205(6):1208-14. PubMed ID: 26587927
[TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
5. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.
Rozenberg R; Thornhill RE; Flood TA; Hakim SW; Lim C; Schieda N
AJR Am J Roentgenol; 2016 Apr; 206(4):775-82. PubMed ID: 27003049
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
Salami SS; Ben-Levi E; Yaskiv O; Turkbey B; Villani R; Rastinehad AR
J Magn Reson Imaging; 2017 Feb; 45(2):610-616. PubMed ID: 27405584
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient.
Xiaohang L; Bingni Z; Liangping Z; Weijun P; Xiaoqun Y; Yong Z
Acta Radiol; 2017 Dec; 58(12):1528-1534. PubMed ID: 28286980
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Tumor Volume in Patients With Prostate Cancer Undergoing Active Surveillance: Is MRI Apparent Diffusion Coefficient Indicative of Tumor Growth?
Morgan VA; Parker C; MacDonald A; Thomas K; deSouza NM
AJR Am J Roentgenol; 2017 Sep; 209(3):620-628. PubMed ID: 28609110
[TBL] [Abstract][Full Text] [Related]
9. Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer?
Faletti R; Battisti G; Discalzi A; Grognardi ML; Martinello S; Oderda M; Gontero P; Bergamasco L; Cassinis MC; Fonio P
Abdom Radiol (NY); 2016 May; 41(5):926-33. PubMed ID: 27193791
[TBL] [Abstract][Full Text] [Related]
10. Exploratory Study of Apparent Diffusion Coefficient Histogram Metrics in Assessing Pancreatic Malignancy.
Taffel MT; Luk L; Ream JM; Rosenkrantz AB
Can Assoc Radiol J; 2019 Nov; 70(4):416-423. PubMed ID: 31604596
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
[TBL] [Abstract][Full Text] [Related]
12. Whole-lesion histogram analysis metrics of the apparent diffusion coefficient as a marker of breast lesions characterization at 1.5 T.
Bougias H; Ghiatas A; Priovolos D; Veliou K; Christou A
Radiography (Lond); 2017 May; 23(2):e41-e46. PubMed ID: 28390558
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.
Li C; Chen M; Wan B; Yu J; Liu M; Zhang W; Wang J
Acta Radiol; 2018 Nov; 59(11):1395-1402. PubMed ID: 29486596
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
15. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient.
Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J
J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
17. Index lesion characterization by (11)C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma.
Hernández-Argüello M; Quiceno H; Pascual I; Solorzano JL; Benito A; Collantes M; Rodríguez-Fraile M; Pardo J; Richter JA
Prostate; 2016 Jan; 76(1):3-12. PubMed ID: 26390847
[TBL] [Abstract][Full Text] [Related]
18. The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.
Nougaret S; Robertson N; Golia Pernicka J; Molinari N; Hötker AM; Ehdaie B; Sala E; Hricak H; Vargas HA
Abdom Radiol (NY); 2017 Jul; 42(7):1968-1974. PubMed ID: 28258355
[TBL] [Abstract][Full Text] [Related]
19. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
[No Abstract] [Full Text] [Related]
20. Evaluation of Exponential ADC (eADC) and Computed DWI (cDWI) for the Detection of Prostate Cancer.
Sprinkart AM; Marx C; Träber F; Block W; Thomas D; Schild H; Kukuk GM; Mürtz P
Rofo; 2018 Aug; 190(8):758-766. PubMed ID: 30045400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
